Kanoria Chemicals Swings to Profit in FY26

Consolidated profit for FY 2025-26 stands at ₹113.20 crore, a significant turnaround from the previous year's loss.

Reader Takeaway: Strong profit recovery driven by improved sales and operational efficiency, but watch raw material costs.

What just happened

Kanoria Chemicals & Industries Ltd announced a robust financial performance for the fiscal year 2025-26. The company achieved a consolidated profit of ₹113.20 crore, a notable recovery from the loss reported in the prior year.

Standalone revenue saw a substantial increase of 29%, reaching ₹875.34 crore. Consolidated revenue also jumped by 30% to ₹981.43 crore.

Why this matters

This profit turnaround signals a positive shift in the company's financial health. The significant revenue growth indicates strong demand and successful execution of business strategies. Capacity expansions in Pentaerythritol and Resin are now complete, positioning the company for future growth.

The backstory

The company's standalone operations benefited from enhanced plant efficiency across its Ankleshwar, Visakhapatnam, and Naidupeta facilities. On the consolidated front, the turnaround in Ethiopian textile operations, which shifted from a loss to a cash profit, along with a 24% revenue increase in that segment, significantly boosted overall results.

What changes now

APAG Holding AG is no longer a subsidiary as of July 31, 2025. The company also increased its authorized capital to ₹100 crore and issued preference shares to R. V. Investment and Dealers Limited to finance capital expenditures and general corporate requirements.

Risks to watch

Management has flagged several concerns, including the volatility of crude oil prices impacting Methanol and Phenol costs. Currency depreciation against the US dollar and competitive pressures from low-cost imports of Sodium Formate and Hexamine are also key watch points.

Peer comparison

While specific peer data is not provided in the filing, Kanoria Chemicals' performance indicates a competitive edge in its chemical segments, particularly with its completed capacity expansions. The turnaround in its international textile operations also suggests adaptability.

Context metrics (time-bound)

• FY 2025-26 Consolidated Profit: ₹113.20 crore (Turnaround from prior year loss)
• FY 2025-26 Standalone Revenue: ₹875.34 crore (up 29%)
• FY 2025-26 Consolidated Revenue: ₹981.43 crore (up 30%)
• FY 2025-26 Standalone EBITDA: ₹81.58 crore (up 52%)
• FY 2025-26 Consolidated EBITDA: ₹93.79 crore (up 90%)

What to track next

Investors will be keen to monitor the performance of new product platforms like Triacetin and Penta Derivatives. The sustainability of the recovery in the Ethiopian textile business and management's ability to navigate raw material price volatility and import competition will be crucial.